Direct antigen detection from immunoprecipitated beads using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; A new method for immunobeads-mass spectrometry (iMS)

Rapid Communications in Mass Spectrometry

Volumn 25, Issue 23, 2011, Pages 3521-3526

  Shimada, Takashi ^a   Toyama, Atsuhiko ^a   Aoki, Chikage ^a   Aoki, Yutaka ^a   Tanaka, Koichi ^a   Sato, Taka Aki ^a  

^a SHIMADZU CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; DESORPTION; DIAGNOSIS; INDUCTIVELY COUPLED PLASMA; MASS SPECTROMETRY; PEPTIDES; SOAPS (DETERGENTS);

ALKYL CHAIN; ANTIGEN DETECTIONS; BIOLOGICAL MOLECULE; CLINICAL DIAGNOSIS; IMMUNOBEADS; IMMUNOPRECIPITATIONS; MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY; MEDICAL SCIENCE; NEW APPROACHES; ONE-STEP DETECTIONS;

BIOMARKERS;

EID: 81555226883     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.5259     Document Type: Article

References (17)

1. O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky,. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study. Neurology 2008, 70, 1664.
2. M. van Oijen, A. Hofman, H. D. Soares, P. J. Koudstaal, M. M. Breteler,. Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol. 2006, 5, 655.
3. A. Brymora, V. A. Valova, P. J. Robinson,. Protein-protein interactions identified by pull-down experiments and mass spectrometry. Curr. Protocols Cell Biol. 2004, chap. 17, unit 17 5.
4. E. A. Elion,. Detection of protein-protein interactions by coprecipitation. Curr. Protocols Mol. Biol. 2006, chap. 20, unit 20 5.
5. X. Zhang, D. Wei, Y. Yap, L. Li, S. Guo, F. Chen,. Mass spectrometry-based "omics" technologies in cancer diagnostics. Mass Spectrom. Rev. 2007, 26, 403.
6. W. Pusch, M. T. Flocco, S. M. Leung, H. Thiele, M. Kostrzewa,. Mass spectrometry-based clinical proteomics. Pharmacogenomics 2003, 4, 463.
7. Y. Fukuyama, S. Nakaya, Y. Yamazaki, K. Tanaka,. Ionic liquid matrixes optimized for MALDI-MS of sulfated/sialylated/neutral oligosaccharides and glycopeptides. Anal. Chem. 2008, 80, 2171.
8. R. Wang, D. Sweeney, S. E. Gandy, S. S. Sisodia,. The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 1996, 271, 31894.
9. Y. Zhao, T. W. Muir, S. B. Kent, E. Tischer, J. M. Scardina, B. T. Chait,. Mapping protein-protein interactions by affinity-directed mass spectrometry. Proc. Natl. Acad. Sci. USA 1996, 93, 4020.
10. N. L. Anderson, N. G. Anderson,. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845.
11. R. Knochenmuss, R. Zenobi,. MALDI ionization: the role of in-plume processes. Chem. Rev. 2003, 103, 441.
12. M. Rey, H. Mrazek, P. Pompach, P. Novak, L. Pelosi, G. Brandolin, E. Forest, V. Havlicek, P. Man,. Effective removal of nonionic detergents in protein mass spectrometry, hydrogen/deuterium exchange, and proteomics. Anal. Chem. 2010, 82, 5107.
13. A. M. Distler, J. Kerner, C. L. Hoppel,. Proteomics of mitochondrial inner and outer membranes. Proteomics 2008, 8, 4066.
14. H. Katayama, T. Nagasu, Y. Oda,. Improvement of in-gel digestion protocol for peptide mass fingerprinting by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2001, 15, 1416.
15. P. Lewczuk, H. Esselmann, M. Otto, J. M. Maler, A. W. Henkel, M. K. Henkel, O. Eikenberg, C. Antz, W. R. Krause, U. Reulbach, J. Kornhuber, J. Wiltfang,. Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau. Neurobiol. Aging 2004, 25, 273.
16. Y. Tomidokoro, A. Rostagno, T. A. Neubert, Y. Lu, G. W. Rebeck, B. Frangione, S. M. Greenberg, J. Ghiso,. Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits. Am. J. Pathol. 2010, 176, 1841.
17. J. Wiltfang, H. Esselmann, M. Bibl, A. Smirnov, M. Otto, S. Paul, B. Schmidt, H. W. Klafki, M. Maler, T. Dyrks, M. Bienert, M. Beyermann, E. Ruther, J. Kornhuber,. Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J. Neurochem. 2002, 81, 481.